Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: A subgroup analysis of the EUROPA trial-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: A subgroup analysis of the EUROPA trial

Published:2009-02 Issue:2 Volume:102 Page:89-96
ISSN:1875-2136
Container-title:Archives of Cardiovascular Diseases
language:en
Short-container-title:Archives of Cardiovascular Diseases

Author:

E. Bertrand Michel,M. Fox Kim,J. Remme Willem,Ferrari Roberto,L. Simoons Maarten

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference14 articles.

1. Ischemic heart disease;Murray,1996

2. Angiotensin-converting-enzyme inhibition in stable coronary artery disease;Braunwald;N Engl J Med,2004

3. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study);Fox;Lancet,2003

4. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function;Pitt;Am J Cardiol,2001

5. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators;Yusuf;N Engl J Med,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ANGIOPROTECTIVE EFFECTS OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC KIDNEY DISEASE STAGES 2-3 AFTER CORONARY STENTING;KARDIOLOGIYA;2021

2. Established and Emerging Pharmacological Therapies for Post-Myocardial Infarction Patients with Heart Failure: a Review of the Evidence;Cardiovascular Drugs and Therapy;2020-06-20

3. Perindopril Improves Cardiac Function by Enhancing the Expression of SIRT3 and PGC-1α in a Rat Model of Isoproterenol-Induced Cardiomyopathy;Frontiers in Pharmacology;2020-02-21

4. Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure;Journal of Hypertension;2017-11

5. Perindopril - angiotensin-converting enzyme inhibitor is approved for usage;Systemic Hypertension;2014-12-15